Protecting the rights of air passengers is a priority of the Government of Canada, and the Government will continue to ensure that travelers' rights are respected by airlines when travel does not go according to plan.
Canada's Minister of Transport, the Honorable Omar Alghabra, announced on April 24, 2023, that proposed amendments to the Canada Transportation Act had been introduced as part of the Budget Implementation Act.
Canadian Flyers Have Rights Too
BCG Vaccine Does Not Reduce COVID-19 Risk for Health Care Workers
No significant difference seen in risk for symptomatic COVID-19, severe COVID-19 for those receiving BCG or saline placebo
HIV and Other Sexually Transmitted Infection Testing Down During Pandemic
Authors say low-barrier alternatives to office-based testing are needed to mitigate testing gaps, high positivity rates
Protein-based COVID-19 Vaccine Over 79% Effective
The JAMA Network today published the results from an Original Investigation on the Novavax COVID-19 vaccine.
In collaboration with the Department of Health and Human Services, Novavax researchers assessed the neutralizing antibody response to its COVID-19 vaccine (NVX-CoV2373) in a phase 3 clinical trial among adolescents from April 26 to June 5, 2021.
Bird Flu Risk Rarely Detected in Humans
Is a bird flu pandemic really a risk to people in 2023? That is the question a group of researchers answered in an Early Release Original Publication posted today.
Since late 2021, the largest bird flu outbreak in history has impacted most countries.
In the U.S., the Centers for Disease Control and Prevention published a June 2023 Dispatch, Volume 29, Number 6, confirming a total of 39 states recently experienced outbreaks of highly pathogenic avian influenza A(H5N1) virus in birds from commercial poultry farms and backyard flocks.
HIV Vaccine Research Accelerates with Government Funding
While millions of people worldwide await the launch of an HIV vaccine, the U.S. government recently took action by committing to fund early-stage vaccine candidates.
On April 26, 2023, Uvax Bio, LLC announced that its HIV vaccine candidates had shown significantly improved immune response compared with current vaccine strategies.
Repeated Low-Level Red-Light Intervention Prevents Myopia in Children
RLRL effective for preventing myopia in children with premyopia, with up to a 54.1 percent reduction in incidence
Rift River Fever Vaccine Candidate Competes Phase 1 Study
In this issue of The Lancet Infectious Diseases, Daniel Jenkin and colleagues reported the results of a phase 1 study of a new ChAdOx1 vector vaccine against Rift Valley fever (RVF).
RVF is a viral zoonosis that primarily affects animals but can infect humans.
The development of an effective human vaccine against RVF that elicits a long-term immune response is of enormous clinical importance, wrote these researchers on April 12, 2023.
New Malaria Vaccine Takes Orders
Two African nations became the first countries to approve the new R21/Matrix-M™ malaria vaccine, developed at Oxford University, includes Novavax's world-class adjuvant, and is manufactured by the Serum Institute of India (SII), Pvt. Ltd.
This year, Ghana and Nigeria preempted the World Health Organization (WHO) process and issued their approvals. And about ten other African countries may issue their approvals soon.
U.S. NIH Herpes Strategic Plan Seeks Proposals
Over the past decade, the United States has witnessed alarming increases in rates of sexually transmitted infections (STIs), amounting to a public health crisis.
The consequences of the STI epidemic are enormous, wrote the U.S. HHS.
When left untreated, STIs can lead to long-term, irreversible health outcomes such as chronic pelvic pain, infertility, adverse pregnancy outcomes, neonatal death, and congenital abnormalities.